Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 241 AL 255

Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial

Sindi S, Ngandu T, Hovatta I, Kåreholt I, Antikainen R, Hänninen T, Levälahti E, Laatikainen T, Lindström J, Paajanen T, Peltonen M, Khalsa DS, Wolozin B, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M, Solomon A; FINGER study group.

J Alzheimers Dis. 2017;59(4):1459-1470. doi: 10.3233/JAD-170123.

Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial

Park KW, Kim EJ, Han HJ, Shim YS, Kwon JC, Ku BD, Park KH, Yi HA, Kim KK, Yang DW, Lee HW, Kang H, Kwon OD, Kim S, Lee JH, Chung EJ, Park SW, Park MY, Yoon B, Kim BC, Seo SW, Choi SH.

PLoS One. 2017 Aug 7;12(8):e0182123. doi: 10.1371/journal.pone.0182123. eCollection 2017.

Alzheimer's Disease Caregivers' Health and Important Resources: Next Steps in Intervention Research

Ross KM, Carroll JE.

Psychosom Med. 2017 Sep;79(7):732-734. doi: 10.1097/PSY.0000000000000518.

Supporting Adults With Alzheimer's Disease and Related Major Neurocognitive Disorders and Their Caregivers: Effective Occupational Therapy Interventions

Smallfield S.

Am J Occup Ther. 2017 Sep/Oct;71(5):7105170010p1-7105170010p4. doi: 10.5014/ajot.2017.715002.

Effectiveness of Interventions for Caregivers of People With Alzheimer's Disease and Related Major Neurocognitive Disorders: A Systematic Review

Piersol CV, Canton K, Connor SE, Giller I, Lipman S, Sager S.

Am J Occup Ther. 2017 Sep/Oct;71(5):7105180020p1-7105180020p10. doi: 10.5014/ajot.2017.027581.

Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years

Wattmo C, Wallin ÅK.

Alzheimers Res Ther. 2017 Aug 31;9(1):70. doi: 10.1186/s13195-017-0294-2.

Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease

Kim SH, Kandiah N, Hsu JL, Suthisisang C, Udommongkol C, Dash A.

Br J Pharmacol. 2017 Dec;174(23):4224-4232. doi: 10.1111/bph.14030. Epub 2017 Oct 29.

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease

Cavedo E, Grothe MJ, Colliot O, Lista S, Chupin M, Dormont D, Houot M, Lehéricy S, Teipel S, Dubois B, Hampel H; Hippocampus Study Group.

Sci Rep. 2017 Sep 15;7(1):11706. doi: 10.1038/s41598-017-09780-3.

[The reconstruction of meaning in dementia]

Thomas P, Chandès G, Hazif-Thomas C.

Soins Gerontol. 2017 Sep-Oct;22(127):41-44. doi: 10.1016/j.sger.2017.06.012.

Acupuncture plus Herbal Medicine for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhou S, Dong L, He Y, Xiao H.

Am J Chin Med. 2017;45(7):1327-1344. doi: 10.1142/S0192415X17500732. Epub 2017 Sep 18.

Everyday Decision Making in Individuals with Early-Stage Alzheimer's Disease: An Integrative Review of the Literature

Davis R, Ziomkowski MK, Veltkamp A.

Res Gerontol Nurs. 2017 Sep 1;10(5):240-247. doi: 10.3928/19404921-20170831-05.

Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD Data

Ozawa C, Roberts R, Yoshida K, Suzuki T, Lebowitz B, Reeves S, Howard R, Abe T, Mimura M, Uchida H.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1204-e1210. doi: 10.4088/JCP.17m11461.

Ethique: Quelques questions face à la démence

Hurst S.

Praxis (Bern 1994). 2017;106(22):1211-1213. doi: 10.1024/1661-8157/a002844.

Developing Disease-Modifying Treatments in Alzheimer's Disease - A Perspective from Roche and Genentech

Doody R.

J Prev Alzheimers Dis. 2017;4(4):264-272. doi: 10.14283/jpad.2017.40.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias